Achievement of Goals in U.S. Diabetes Care, 1999–2010
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tracking national progress in diabetes care may aid in the evaluation of past efforts and identify residual gaps in care. METHODS: We analyzed data for adults with self-reported diabetes from the National Health and Nutrition Examination Survey and the Behavioral Risk Factor Surveillance System to examine risk-factor control, preventive practices, and risk scores for coronary heart disease over the 1999-2010 period. RESULTS: From 1999 through 2010, the weighted proportion of survey participants who met recommended goals for diabetes care increased, by 7.9 percentage points (95% confidence interval [CI], 0.8 to 15.0) for glycemic control (glycated hemoglobin level <7.0%), 9.4 percentage points (95% CI, 3.0 to 15.8) for individualized glycemic targets, 11.7 percentage points (95% CI, 5.7 to 17.7) for blood pressure (target, <130/80 mm Hg), and 20.8 percentage points (95% CI, 11.6 to 30.0) for lipid levels (target level of low-density lipoprotein [LDL] cholesterol, <100 mg per deciliter [2.6 mmol per liter]). Tobacco use did not change significantly, but the 10-year probability of coronary heart disease decreased by 2.8 to 3.7 percentage points. However, 33.4 to 48.7% of persons with diabetes still did not meet the targets for glycemic control, blood pressure, or LDL cholesterol level. Only 14.3% met the targets for all three of these measures and for tobacco use. Adherence to the recommendations for annual eye and dental examinations was unchanged, but annual lipid-level measurement and foot examination increased by 5.5 percentage points (95% CI, 1.6 to 9.4) and 6.8 percentage points (95% CI, 4.8 to 8.8), respectively. Annual vaccination for influenza and receipt of pneumococcal vaccination for participants 65 years of age or older rose by 4.5 percentage points (95% CI, 0.8 to 8.2) and 6.9 percentage points (95% CI, 3.4 to 10.4), respectively, and daily glucose monitoring increased by 12.7 percentage points (95% CI, 10.3 to 15.1). CONCLUSIONS: Although there were improvements in risk-factor control and adherence to preventive practices from 1999 to 2010, tobacco use remained high, and almost half of U.S. adults with diabetes did not meet the recommended goals for diabetes care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Still, many do not meet the recommended goals for diabetes care [7-9]; in Norway, research has shown that only 20% attain the target for metabolic control for glycated hemoglobin A1c (HbA1c), blood pressure, and lipid level, although the quality of care has improved [8].”
In the citing paper
“there is evidence that measures of 10-year CHD risk among U.S. adults with diabetes have improved signi fi cantly over the past decade (2)”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [2]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Research works printed but not linked: 2
- Ahmann AJ, 2007, Am J Manag Care, 13, S41
- Gary TL, 2003, Ethn Dis, 13, 47
Cited by
Items 501–600 of 978
Goh, L. G. H., Sun, J., Ong, B. S. K., Khoo, D. H. C., Sum, C. F., & Ng, K. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01004-4 · Cited by 14
“9 years [7], compared to 13% in the United States (US) population aged between 18 to 44 years [8].”
Backgroundde Lusignan, S., McGovern, A. P., Hinton, W., Whyte, M., Munro, N. M., Williams, E. D., Marcu, A., Williams, J., Ferreira, F. M., Mount, J., et al. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01306-z · Cited by 15
Continuity of Medication Use by US Adults With Diabetes, 2005-2019
Chehal, P. K., Uppal, T. S., Turbow, S. D., Fernandes, G. F., HAW, J. S., Shah, M. K., Rajpathak, S. N., Narayan, K. M. V., & Ali, M. K. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.53562 · Cited by 13
Self-citationFerdinand, K. C., Dunn, J. P., Nicolay, C., Sam, F., Blue, E. K., & Wang, H. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01775-x · Cited by 14
“However, up to half of patients do not achieve these goals [11, 12].”
BackgroundTeam Process Variation Across Diabetes Quality of Care Trajectories
Benzer, J. K., Mohr, D. C., Evans, L. C., Young, G. J., Meterko, M. M., Moore, S. C., Seibert, M. N., Osatuke, K., Stolzmann, K. L., White, B., et al. (2015) · Medical Care Research and Review · doi:10.1177/1077558715617380 · Cited by 17
Schernthaner, G., Lavalle-Gonzalez, F. J., Davidson, J. A., Jodon, H., Vijapurkar, U., Qiu, R., & Canovatchel, W. J. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1210988 · Cited by 13
“related to body weight, blood pressure, and cholesterol [1,2].”
BackgroundGibson, D. M. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.09.019 · Cited by 16
Feng, L., Naheed, A., de Silva, H. A., Jehan, I., Raqib, R., Islam, M. T., Luke, N. V., Kasturiratne, A., Farazdaq, H., Senan, S., et al. (2019) · Journal of Obesity · doi:10.1155/2019/4914158 · Cited by 14
“BP control and lipid-lowering are key for preventing diabetes-related vascular complications [58, 59].”
BackgroundLong-term outcomes of bariatric surgery in patients with diabetes
Sudlow, A. C., le Roux, C. W., & Pournaras, D. J. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1754191 · Cited by 15
“A study looking at diabetes care found only half of the patients achieved targets with respect to glycemic control with numbers falling to only 20% when looking at those achieving all three therapeutic targets (hyperglycemia, hypertension, and dyslipidemia) as stipulated by the ADA [17].”
BackgroundInfluentialDiabetes and age-related demographic differences in risk factor control
Egan, B. M., Li, J., Wolfman, T. E., & Sinopoli, A. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.03.323 · Cited by 15
“The linkage of diabetes control to insurance and visit frequency in younger patients is consistent with previous reports [33], whereas linkage to BP medication is more speculative and may not be causal.”
ResultSharma, A. (2014) · Applied Geography · doi:10.1016/j.apgeog.2014.09.017 · Cited by 14
Liatis, S., Papaoikonomou, S., GANOTOPOULOU, A., Papazafiropoulou, A. K., Dinos, C., Michail, M., Xilomenos, A., Melidonis, A. J., & Pappas, S. I. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-23 · Cited by 16
“Duration of diabetes (years)* 9 [4-16] 12 [7-19] < 0.”
ResultWang, Z., & Liu, M. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.06.015 · Cited by 15
Racial differences in spatial patterns for poor glycemic control in the Southeastern United States
Walker, R. J., Neelon, B., Davis, M. L., & Egede, L. E. (2018) · Annals of Epidemiology · doi:10.1016/j.annepidem.2018.01.008 · Cited by 14
“(5,6) Evidence consistently shows racial minorities have higher prevalence of diabetes, worse diabetes outcomes, higher risk of complications, worse glycemic control, and higher mortality rates compared to non-Hispanic whites (NHW), including an equal access system like the Veterans Health Administration (VA).”
BackgroundSecondary Prevention of Dementia: Combining Risk Factors and Scalable Screening Technology
Ojakäär, T., & Koychev, I. G. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.772836 · Cited by 14
“The effectiveness of treatment options for diabetes have improved incrementally over the past few decades (32), thus increasing the lifespan of patients.”
BackgroundGiugliano, D., Longo, M., Scappaticcio, L., Caruso, P., Gicchino, M., Petrizzo, M., Bellastella, G., Maiorino, M. I., & Esposito, K. (2023) · Endocrine · doi:10.1007/s12020-023-03547-9 · Cited by 12
“However, many individuals fail to achieve adequate lowering of glycated hemoglobin (HbA1c), even when using complex insulin regimens [2 – 4].”
BackgroundBerkowitz, S. A., Atlas, S. J., Grant, R. W., & Wexler, D. J. (2014) · Diabetic Medicine · doi:10.1111/dme.12427 · Cited by 12
Rao, D. T., Sunio, L. K. F., Lo, Y.-J., & Gossain, V. V. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0158-x · Cited by 14
“[11] where they analyzed the quality of diabetes care in the US from 1999 to 2010.”
BackgroundInfluentialDuhon, B. M., Hand, E., Howell, C. K., & Reveles, K. R. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.09.012 · Cited by 16
Predictors of Self-Efficacy in Administering Insulin Injection
Huang, M., Hung, C., Huang, Y.-W., & Yang, S.-C. (2019) · Clinical Nursing Research · doi:10.1177/1054773819858484 · Cited by 12
“Dietary control, regular exercise, and medication therapy are necessary to maintain glycated hemoglobin (HbA1c) levels below 7% (American Diabetes Association, 2018).”
BackgroundInfluentialAccessing diabetes care in rural Uganda: Economic and social resources
Nielsen, J., Bahendeka, S., Bygbjerg, I. C., Meyrowitsch, D. W., & Whyte, S. R. (2016) · Global Public Health · doi:10.1080/17441692.2016.1172100 · Cited by 12
“For this present qualitative study, the 10 patients were purposefully chosen to represent both genders and different levels of control of T2D (defined by glycosylated haemoglobin [HbA1c] according to Ali et al., 2013).”
MethodLixisenatide – A New Glucagon-like Peptide 1 Receptor Agonist in the Treatment of Type 2 Diabetes
Vidal, J. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2013.09.02.76 · Cited by 15
Healthy lifestyle intervention for adult clinic patients with type 2 diabetes mellitus.
Coughlin, S. S., Hatzigeorgiou, C., Anglin, J. C., Xie, D., Besenyi, G. M., Leo, G. D., Stewart, J. L., & Wilkins, T. (2017) · PubMed · Cited by 12
Aronson, R., Brown, R. E., Jiandani, D., Walker, A., Orzech, N., & Mbuagbaw, L. C. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.10.028 · Cited by 13
Liss, D. T., Finch, E. A., Cooper, A., Sheth, A., Tejuosho, A. D., Lancki, N., & Ackermann, R. T. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.030 · Cited by 13
Hirsch, I. B., Nardacci, E., & Verderese, C. A. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0059 · Cited by 14
Mendivil, C. O., Amaya-Montoya, M., Vargas, J. A. H., Ramírez-García, N., Romero-Díaz, C., Pérez-Londoño, A., Guatibonza-García, V., & Acuña-Merchán, L. A. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109823 · Cited by 15
Waddimba, A. C., Beckman, H., Mahoney, T. L., & Burgess, J. F. (2016) · Medical Care Research and Review · doi:10.1177/1077558716628354 · Cited by 15
“Yet half of adult Americans with diabetes still do not receive guideline-adherent care (Ali et al., 2013), and 70,000 Americans die from diabetes complications every year (National Committee for Quality Assurance, 2013).”
BackgroundThorpe, L. E., Kanchi, R., Chamany, S., Rodriguez-Lopez, J. S., Chernov, C., Freeman, A. L., & Perlman, S. E. (2018) · Journal of Urban Health · doi:10.1007/s11524-018-0285-z · Cited by 12
Diabetes Treatment, Control, and Hospitalization Among Adults Aged 18 to 44 in Minnesota, 2013–2015
Styles, E., Kidney, R. S. M., Carlin, C., & PETERSON, K. A. (2018) · Preventing Chronic Disease · doi:10.5888/pcd15.180255 · Cited by 12
Gabriel, R. A., Hylton, D. J., Burton, B. N., Schmidt, U. H., & Waterman, R. S. (2019) · Journal of Perioperative Practice · doi:10.1177/1750458919886183 · Cited by 12
Diabetes Deprescribing in Older Adults: A Randomized Clinical Trial
Grant, R. W., Peterson, I., McCloskey, J. M., Lipska, K. J., Nugent, J., Karter, A. J., & Gilliam, L. K. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.2015 · Cited by 11
Kim, H. S., Cho, Y. K., Kim, M., Jung, C. H., Park, J., & Lee, W. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1032793 · Cited by 11
Overview on chronic complications of diabetes mellitus
Vlacho, B., Rossell-Rusiñol, J., Granado-Casas, M., Mauricio, D., & Julve, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-88426-6.00009-9 · Cited by 18
Li, B., Cheng, X., Huang, Y., Zhou, C., Gu, C., Zhu, X., Li, C., Ma, M., Fan, Y., Xu, X., et al. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02328-8 · Cited by 12
“Cardiovascular diseases (CVD) were defined by existence of any self-reported congestive heart failure, coronary heart disease, heart attack, or stroke [ 9 ].”
Thomsen, C. H. N., Kronborg, T., Hangaard, S., Vestergaard, P., & Jensen, M. H. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2024.105783 · Cited by 13
Bailey, R. A., Vijapurkar, U., Meininger, G. E., Rupnow, M. F. T., & Blonde, L. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.02.020 · Cited by 11
Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes
Aronoff, S. L. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1285191 · Cited by 11
“[4], and evidence suggests that this could be due in part to inadequate management of postprandial glucose (PPG) [3,5,6].”
BackgroundFitch, K., Engel, T., Sander, S. D., Kuti, E. L., & Blumen, H. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1346595 · Cited by 13
“Although strategies to prevent and control diabetes have been associated with costsavings or cost-effectiveness,(18) findings from the National Health and Nutrition Examination Survey and Behavioral Risk Factor Surveillance System show that nearly 50% of US adults with diabetes did not meet the recommended goals for d…”
BackgroundCarnagarin, R., Kiuchi, M. G., Goh, G. S., Adams, L. A., Cohen, N. D., Kavnoudias, H., Gan, S. K., van Schie, G., Esler, M., Matthews, V. B., et al. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002839 · Cited by 11
“As a result of poor adherence and ineffectiveness of drugs to treat underlying causes, most patients with T2DM do not achieve normal plasma glucose levels and remain in a poorly controlled, pathologic haemoglobin A1C range [88,89].”
BackgroundSeki, Y., Kasama, K., Yokoyama, R., Maki, A., Shimizu, H., Park, H., & Kurokawa, Y. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13631 · Cited by 15
Lee, C., Hsing, S.-C., Lin, Y.-T., Lin, C. S., Chen, J., Chen, Y., & Fang, W. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18189768 · Cited by 13
“However, 30–50% of patients did not meet individualized HbA1c targets at the recommended levels [19].”
BackgroundGrauer, A., Duran, A. T., Liyanage-Don, N. A., Torres‐Deas, L. M., Metser, G., Moise, N., Kronish, I. M., & Ye, S. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01814-6 · Cited by 12
“As described previously, a recent study based on NHANES data showed that only 21% of patients with diagnosed diabetes had all three measurements controlled between 2015 and 2018 [3], which only modestly improved from the previous decade [7, 8].”
BackgroundResultEvert, A. B., & Riddell, M. C. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.09.001 · Cited by 24
Sathe, N. A., Nocon, R. S., Hughes, B. L., Peek, M. E., Chin, M. H., & Huang, E. S. (2016) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(16)42002-7 · Cited by 11
Type 2 Diabetes Treatment in the Patient with Obesity
Malin, S. K., & Kashyap, S. R. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.04.007 · Cited by 15
Metabolic Surgery Enters the T2DM Treatment Algorithm
Moncada, R., Landecho, M. F., & Frühbeck, G. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.07.006 · Cited by 12
Carretero‐Gómez, J., Arévalo‐Lorido, J. C., Huelgas, R. G., Vidal, M. T. S., Tembra, M. S., Aguilar, J. M. V., Voces, I. M., Pérez, E. F., Rodríguez, J. M. F., & Muñoz, J. E. (2017) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2016.12.003 · Cited by 12
Use of a web portal among adult clinic patients seen for type 2 diabetes mellitus
Coughlin, S. S., Heboyan, V., Williams, L. B., & Hatzigeorgiou, C. (2018) · Journal of Hospital Management and Health Policy · doi:10.21037/jhmhp.2017.12.04 · Cited by 11
“Good glycemic control is associated with reduced morbidity and mortality, but almost half of patients with type 2 diabetes do not meet recommended targets for glycemic control, or cholesterol control, or blood pressure control (3-5).”
BackgroundMercado, C. I., Gregg, E. W., Gillespie, C., & Loustalot, F. V. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193756 · Cited by 12
Self-citationLee, A. S., Colagiuri, S., & Flack, J. R. (2018) · Diabetic Medicine · doi:10.1111/dme.13635 · Cited by 11
Heidemann, C., Du, Y., Baumert, J. J., Paprott, R., Lampert, T., & Scheidt‐Nave, C. (2019) · Publication server of the Robert Koch Institute (Robert Kock Institute) · doi:10.25646/5986 · Cited by 22
Nagpal, J., Rawat, S., Goyal, S., & Lata, A. S. (2021) · Diabetic Medicine · doi:10.1111/dme.14530 · Cited by 11
New aspects in the management of hypertension in the digital era
Milani, R. V., Lavie, C. J., & Ventura, H. O. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000870 · Cited by 14
Management of hyperglycemia in type 2 diabetes: evidence and uncertainty
Esposito, K., Gentile, S., Candido, R., Micheli, A. D., Gallo, M., Medea, G., Ceriello, A., & (AMD), O. B. O. A. M. D. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-81 · Cited by 11
“3% met the targets for all three measures of glycemic control (HbA1c <7%), blood pressure (<130/80 mm Hg), or LDL cholesterol (<100 mg/dl) level [2].”
BackgroundNielsen, J., Bahendeka, S., Bygbjerg, I. C., Meyrowitsch, D. W., & Whyte, S. R. (2016) · Health Education & Behavior · doi:10.1177/1090198115610569 · Cited by 13
“From this cohort the 10 patients were purposefully selected to represent both genders and different levels of control of T2D (defined by glycosylated hemoglobin [HbA1c] according to Ali et al., 2013).”
MethodRovner, B. W., & Casten, R. J. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.03.012 · Cited by 11
“, handling money, shopping); responses range from “no difficulty” (1) to “does not do this activity” (4).”
BackgroundMethodBlonde, L., Patel, C. A., Bookhart, B., Pfeifer, M., Chen, Y., & Wu, B. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1458709 · Cited by 11
Miranda, J. J., Lazo‐Porras, M., Bernabé‐Ortiz, A., Pesantes, M. A., Diez‐Canseco, F., Cornejo, S. D. P., & Trujillo, A. J. (2018) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14824.1 · Cited by 11
Sadarangani, K. P., Astrid von Oetinger, G., Isla, N. S., & Martínez‐Gómez, D. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.01.009 · Cited by 14
Santos, E. E., Korah, J., Subramanian, S., Murugappan, V., Huang, E. S., Laiteerapong, N., & Çınar, A. (2021) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2021.3052809 · Cited by 11
“Preliminary studies have shown that only 65% of U.S. patients meet their individualized glycemic goal [3] and this rate increased modestly by 9% over the last decade.”
BackgroundScreening for Hyperglycemia: The Gateway to Diabetes Prevention and Management for All Americans
Narayan, K. M. V., & Weber, M. B. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0798 · Cited by 13
“In addition to its toll on health, diabetes costs the United States $245 billion annually, including $176 billion from direct health care costs (2).”
BackgroundThe 2015 Standards for Diabetes Care: Maintaining a Patient-Centered Approach
Romeo, G. R., & Abrahamson, M. J. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0385 · Cited by 11
“Because greater than 40% of patients with type 2 diabetes still do not meet their hemoglobin A1c goal (5), outcomes from the GRADE study should guide further optimization of antidiabetic treatment.”
BackgroundEpidemiology of Type 2 Diabetes
Ronald, C. W., & Tong, P. C. Y. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch5 · Cited by 20
Coleman, C. I., Pandya, S., Wang, L., Baser, O., Cai, J., Ingham, M., & Bookhart, B. (2019) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2019-0002 · Cited by 10
Ali, M. K., Singh, K., Kondal, D., Devarajan, R., Patel, S. A., Menon, V. U., Varthakavi, P. K., Vishwanathan, V., Dharmalingam, M., Bantwal, G., et al. (2024) · PLOS Medicine · doi:10.1371/journal.pmed.1004335 · Cited by 10
Self-citationMeece, J. D. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0491-1 · Cited by 16
Wang, Y., Freeman, A., Ajjan, R., Galdo, F. D., & Tiganescu, A. (2022) · Skin Health and Disease · doi:10.1002/ski2.203 · Cited by 10
Michael, G., Peng, X., Geremakis, C. M., & Bae, J. P. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.12.1204 · Cited by 10
Diabetes, Therapeutic Inertia, and Patients’ Medication Experience
Bzowyckyj, A. S., & Begert, J. E. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0019 · Cited by 11
“Despite decades of research investigating the importance of achieving diabetes-related goals and countless innovations introduced in the field of diabetes, slightly less than half of adults living with diabetes in the United States met recommended goals for comprehensive diabetes care in 2010 (1).”
BackgroundUsman, M., Khunti, K., Davies, M. J., & Gillies, C. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.08.008 · Cited by 11
Masood, M. Q., Singh, K., Kondal, D., Ali, M. K., Mawani, M., Devarajan, R., Menon, U. V., Varthakavi, P. K., Viswanathan, V., Dharmalingam, M., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108555 · Cited by 12
Self-citationKumari, G., Singh, V., Chhajer, B., & Jhingan, A. K. (2021) · Acta Scientiarum Health Sciences · doi:10.4025/actascihealthsci.v43i1.53729 · Cited by 15
Wang, J., Lo, S., Yeh, Y., Hwu, C., Huang, C., Hsieh, C., & Sheu, W. H. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14410 · Cited by 12
Xiang, A. S., Szwarcbard, N., Gašević, D., Earnest, A., Pease, A., Andrikopoulos, S., Wischer, N., Davis, W. A., & Zoungas, S. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14506 · Cited by 11
New Approaches to Diabetic Nephropathy from Bed to Bench
Tsai, J.-L., Chen, C., Wu, M., & Tsai, S. (2022) · Biomedicines · doi:10.3390/biomedicines10040876 · Cited by 11
Lin, C., Yeong, T. J. J., Lim, W. H., Ng, C. H., Yau, C. E., Chin, Y. H., Muthiah, M. D., Loh, P. H., Foo, R., Mok, S. F., et al. (2022) · Obesity · doi:10.1002/oby.23453 · Cited by 12
“6 mmoL/L and blood pressure < 130/80mmHg, as recommended to minimize cardiovascular morbidity and mortality (33).”
BackgroundElectronic Documentation of Lifestyle Counseling and Glycemic Control in Patients With Diabetes
Hosomura, N., Goldberg, S. I., Shubina, M., Zhang, M. F., & Turchin, A. (2015) · Diabetes Care · doi:10.2337/dc14-2016 · Cited by 13
Blonde, L., Woo, V. C., Mathieu, C., Yee, J., Vijapurkar, U., Canovatchel, W. J., & Meininger, G. E. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1082991 · Cited by 10
Fu, H., Cao, D., Boye, K. S., Curtis, B. H., Schuster, D., Kendall, D. M., & Ascher‐Svanum, H. (2015) · Diabetes Therapy · doi:10.1007/s13300-015-0119-x · Cited by 10
Impact of Secondary Prevention in an Occupational High-Risk Group
Welch, L. S., Dement, J. M., Ringen, K., Cranford, K., & Quinn, P. S. (2016) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000000925 · Cited by 10
Montvida, O., Cai, X., & Paul, S. K. (2019) · Diabetes Care · doi:10.2337/dc18-1865 · Cited by 10
Kim, K., Unni, S. K., Brixner, D. I., Thomas, S. M., Olsen, C. J., Sterling, K. L., Mitchell, M., & McAdam‐Marx, C. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13694 · Cited by 13
“Despite this evidence, ~50% of patients with T2DM fail to attain optimal glycaemic control.(6) Pharmacotherapy intensification is generally recommended when glycaemic level is inadequately controlled despite acceptable medication adherence.”
Backgroundde Vries, T. I., de Valk, H. W., van der Graaf, Y., de Borst, G. J., Cramer, M. J., Kappelle, L. J., Visseren, F. L. J., & Westerink, J. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107880 · Cited by 11
Giorda, C. B., Pisani, F., Micheli, A. D., Ponzani, P., Russo, G. T., Guaita, G., Zilich, R., & Musacchio, N. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001362 · Cited by 11
¿Necesitamos nuevos tratamientos para la diabetes tipo 2?
Peralta, F. G., & Padín, C. A. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.10.013 · Cited by 10
He, X., Pan, J., Pan, M., Wang, J., Dong, J., Yuan, H., Zhou, L., Chen, M., Chen, Y., Lu, Y., et al. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12458 · Cited by 11
Hypertension and Diabetic Nephropathy
Skov, J., Christiansen, J. S., & Poulsen, P. L. (2016) · Endocrine development · doi:10.1159/000439393 · Cited by 13
Use of Automated Bolus Calculators for Diabetes Management
Schwartz, F., & Marling, C. R. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2013.09.02.92 · Cited by 11
Bała, M. M., Płaczkiewicz‐Jankowska, E., Leśniak, W., Topór‐Mądry, R., Jankowski, M., Grzeszczak, W., Sieradzki, J., & For the ARETAEUS-two Study Group Under the patronage of Diabetes Poland (2014) · Endokrynologia Polska · doi:10.5603/ep.2014.0022 · Cited by 10
“patients [26] showed improvements in diabetes control over 12 years, but only 14% of patients met all their treatment goals (HbA1c ≤ 7% and individualised goals, BP < 130/80 mm Hg and LDL-cholesterol < 100 mg/dL and < 70 mg/dL in those with CHD) and achieved non-smoking status, which is slightly better than in our stu…”
ResultUnderstanding Population Health Through Diabetes Population Management
Mitri, J., & Gabbay, R. A. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.006 · Cited by 12
Perreault, L., Færch, K., & Gregg, E. W. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0899-7 · Cited by 12
Self-citationNovel Methods and Data Sources for Surveillance of State-Level Diabetes and Prediabetes Prevalence
Mardon, R., Marker, D. A., Nooney, J. G., Campione, J. R., Jenkins, F., Johnson, M. C., Merrill, L. S., Rolka, D. B., Saydah, S., Geiss, L. S., et al. (2017) · Preventing Chronic Disease · doi:10.5888/pcd14.160572 · Cited by 10
Shen, J. I., Nicholas, S. B., Williams, S., & Norris, K. C. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1251-4 · Cited by 10
Onyia, A., Berhie, G., Cecchetti, A. A., & Hines, A. L. (2023) · Journal of Patient Experience · doi:10.1177/23743735231188835 · Cited by 10
Muharram, F. R., Swannjo, J. B., Tahapary, D. L., Nasution, S. A., & Oceandy, D. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101759 · Cited by 11
“13,22,23 Colombia and China are examples of developing countries with the best performance in diabetes care, maintaining 48%–64% of their diagnosed diabetes population on the HbA1c target and 20% in the composite target.”
IDegLira for type 2 diabetes: a systematic review and meta-analysis
Liu, Y., Li, X., Zheng, Y., Wang, X., & Wang, X. (2023) · Endocrine · doi:10.1007/s12020-023-03543-z · Cited by 10
“In clinical practice, patients with diabetes often do not reach their haemoglobin A1c (HbA1c) targets [2, 3].”
Lord, J., & Odoi, A. (2024) · International Journal of Health Geographics · doi:10.1186/s12942-023-00360-5 · Cited by 12
“Future ecological studies should consider spatial scale as well as geographic location when investigating determinants of diabetes and other chronic disease outcomes. in DRH rates, it is important to close gaps in adherence to preventive practices and utilization of diabetes care [7, 8].”
BackgroundThe Patient-Centered Medical Neighborhood and Diabetes Care
Spatz, C. M., & Gabbay, R. A. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.2.131 · Cited by 11
Bailey, R. A., Schwab, P., Xu, Y., Pasquale, M. K., & Renda, A. M. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.07.009 · Cited by 9
Metadata
- Authors
- Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-04-25
- Volume
- 368
- Issue
- 17
- Pages
- 1613-1624
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2124234371
- Cited by
- 979
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 31 · 2023: 45 · 2022: 57 · 2021: 61 · 2020: 77 · 2019: 106 · 2018: 98 · 2017: 112 · 2016: 106 · 2015: 112 · 2014: 97 · 2013: 33
- FWCI
- 91.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes management, glycemic control, HbA1c, blood pressure control, LDL cholesterol, tobacco use, coronary heart disease risk, preventive medicine, annual eye examination, foot examination, influenza vaccination, pneumococcal vaccination, self-monitoring of blood glucose, health disparities, NHANES, Behavioral Risk Factor Surveillance System
- MeSH terms
- Adolescent, Adult, Aged, Diabetes Mellitus, Female, Health Promotion, Glycated Hemoglobin, Humans, Male, Middle Aged, Nutrition Surveys, Patient Compliance, Risk Factors, Socioeconomic Factors, United States, Body Mass Index, Outcome Assessment, Health Care, Age Distribution, Sex Distribution, Quality Indicators, Health Care, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.